Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy

被引：0

作者：

Steinchen, N. ^{[1
]}

Mueller-Ladner, U. ^{[2
]}

Lange, U. ^{[2
]}

机构：

[1] Rheumatol Kassel, Kassel, Germany

[2] Univ Giessen, Campus Kerckhoff, Abt Rheumatol, Klin Immunol,Osteol,Phys Med, Benekestr 2-8, D-61231 Bad Nauheim, Germany

来源：

ZEITSCHRIFT FUR RHEUMATOLOGIE | 2020年 / 79卷 / 06期

关键词：

Immunsuppression; Biological therapy; Rheumatoid arthritis; COVID-19; infection; Positive antibody status SARS-CoV2; RHEUMATOID-ARTHRITIS; EULAR RECOMMENDATIONS;

D O I：

10.1007/s00393-020-00824-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A case with rheumatoid arthritis and insufficient compensation under disease-modifying combined long-term therapy with methotrexate and leflunomide is reported. After recovery from a COVID-19 infection, a tumor necrosis factor (TNF) inhibitor therapy was initiated. Until now no reactivation of the COVID-19 infection with positive SARS-CoV-2 antibody status has occurred.

引用

页码：574 / 577

页数：4

共 6 条

[1]

[Anonymous], 2020, ENTZ MED SCHUTZ COVI

[2]

Krüger K, 2018, INTERNIST, V59, P341, DOI 10.1007/s00108-018-0397-2

[3]

Krüger K, 2012, Z RHEUMATOL, V71, P592, DOI 10.1007/s00393-012-1038-0

[4]

Schulze-Koops H, 2020, Z RHEUMATOL, V79, P385, DOI 10.1007/s00393-020-00799-y

[5] Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force [J].

Smolen, Josef S. ;

Breedveld, Ferdinand C. ;

Burmester, Gerd R. ;

Bykerk, Vivian ;

Dougados, Maxime ;

Emery, Paul ;

Kvien, Tore K. ;

Navarro-Compan, M. Victoria ;

Oliver, Susan ;

Schoels, Monika ;

Scholte-Voshaar, Marieke ;

Stamm, Tanja ;

Stoffer, Michaela ;

Takeuchi, Tsutomu ;

Aletaha, Daniel ;

Louis Andreu, Jose ;

Aringer, Martin ;

Bergman, Martin ;

Betteridge, Neil ;

Bijlsma, Hans ;

Burkhardt, Harald ;

Cardiel, Mario ;

Combe, Bernard ;

Durez, Patrick ;

Fonseca, Joao Eurico ;

Gibofsky, Alan ;

Gomez-Reino, Juan J. ;

Graninger, Winfried ;

Hannonen, Pekka ;

Haraoui, Boulos ;

Kouloumas, Marios ;

Landewe, Robert ;

Martin-Mola, Emilio ;

Nash, Peter ;

Ostergaard, Mikkel ;

Ostor, Andrew ;

Richards, Pam ;

Sokka-Isler, Tuulikki ;

Thorne, Carter ;

Tzioufas, Athanasios G. ;

van Vollenhoven, Ronald ;

de Wit, Martinus ;

van der Heijde, Desiree .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) :3-15

[6] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update [J].

Smolen, Josef S. ;

Landewe, Robert ;

Bijlsma, Johannes ;

Burmester, Gerd ;

Chatzidionysiou, Katerina ;

Dougados, Maxime ;

Nam, Jackie ;

Ramiro, Sofia ;

Voshaar, Marieke ;

van Vollenhoven, Ronald ;

Aletaha, Daniel ;

Aringer, Martin ;

Boers, Maarten ;

Buckley, Chris D. ;

Buttgereit, Frank ;

Bykerk, Vivian ;

Cardiel, Mario ;

Combe, Bernard ;

Cutolo, Maurizio ;

van Eijk-Hustings, Yvonne ;

Emery, Paul ;

Finckh, Axel ;

Gabay, Cem ;

Gomez-Reino, Juan ;

Gossec, Laure ;

Gottenberg, Jacques-Eric ;

Hazes, Johanna M. W. ;

Huizinga, Tom ;

Jani, Meghna ;

Karateev, Dmitry ;

Kouloumas, Marios ;

Kvien, Tore ;

Li, Zhanguo ;

Mariette, Xavier ;

McInnes, Iain ;

Mysler, Eduardo ;

Nash, Peter ;

Pavelka, Karel ;

Poor, Gyula ;

Richez, Christophe ;

van Riel, Piet ;

Rubbert-Roth, Andrea ;

Saag, Kenneth ;

da Silva, Jose ;

Stamm, Tanja ;

Takeuchi, Tsutomu ;

Westhovens, Rene ;

de Wit, Maarten ;

van der Heijde, Desiree .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) :960-977

← 1 →